Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

PLD is an effective and safer alternative for treating breast cancer.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Some breast cancer chemotherapy can cause permanent hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Children with cancer had slightly more unusual facial shapes than healthy kids, but not enough to easily tell them apart.

Physical activity, height, and smoking affect prostate cancer risk.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

A group has developed therapies that show promise for treating cancer and various other conditions.